SPRWF News Saturday, May 24, 2014 10:31:57 PM $SPRWF
Supreme Pharmaceuticals Acquires Ontario Greenhouse Complex for Future Medical Marijuana Production
Marketwire - Fri May 23, 8:02AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Company"
(CSE: SL)(OTCBB: SPRWF) is pleased to announce that subsequent to its visit to the 342,000 square foot green house facility in Southern Ontario, Supreme has closed its purchase. The facility is located approximately 100 miles outside of Toronto. This facility is where production will commence after installation of the required security measures and subsequent receipt of final MMPR approval. The Company has started the process of upgrading the property. The facility is located in a specially created high energy use industrial park. It is located next to an unlimited supply of electricity at a very competitive rate, has year round road access and is conveniently located in respect to shipping logistics. It appears that all local use permits are in place such that production can commence immediately upon receipt of the final MMPR license.
Supreme Pharmaceuticals Senior Management to Visit Southern Ontario Facility
Marketwire - Fri May 16, 11:49AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Company" (CSE: SL)(OTCBB: SPRWF) is pleased to announce that senior management of the target company and of Supreme will visit the 342,000 square foot facility in Southern Ontario early next week, of which Supreme currently has the option to purchase. The facility is located approximately 100 miles outside of Toronto. This visit is part of the Company's due diligence on the facility where production is planned to commence upon implementation of the required security measures and receiving final MMPR approval.
Major Medical Marijuana Acquisition Extends BC Company's Winning Streak
GlobeNewswire - Tue May 13, 9:30AM CDT
Needless to say, the M&A activity in the Medical Marijuana space is only going to pick up speed. Less than six weeks since the new Federal rules kicked in, companies are moving quickly to position themselves in this explosive market.
IIROC Trade Resumption - SL
CNW Group - Tue May 13, 9:14AM CDT
Trading resumes in:
Supreme Pharmaceuticals Inc. Announces Second Acquisition Target
Marketwire - Tue May 13, 9:02AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Company" (CSE: SL)(OTCBB: SPRWF) is pleased to report that the Company has signed a letter of intent ("LOI" to acquire a green house facility and 100% of a Southern Ontario based company (the "Target Company" that has been approved for a pre-build Marijuana for Medical Purposes Regulations license ("MMPR Licence". Under the terms of the MMPR License, the Target Company can build out and operate a 342,000 square foot facility that can produce up to 24,000,000 grams (24,000 kilograms) of medicinal marijuana per year. Supreme has made an initial $250,000 payment under the terms of the LOI, and must, by May 22nd, 2014 advance to the Target Company an additional $750,000, at which time Supreme will own the Facility, as described below. The transaction terms contained in the LOI are binding on the parties, subject to final documentation. Supreme currently has the necessary funds on hand to close this portion of the transaction.
IIROC Trading Halt - SL
CNW Group - Tue May 13, 8:00AM CDT
The following issues have been halted by IIROC:
Supreme Grants Incentive Options
Marketwire - Wed May 07, 5:07AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (CSE: SL)(OTCBB: SPRWF) has granted 12,000,000 incentive stock options to directors, officers and consultants at an exercise price of $0.05 for a term of five years from this day May 5th, 2014.
In the Medical Marijuana Market, Pick a Winner
GlobeNewswire - Thu May 01, 9:40AM CDT
Most savvy investors are aware of the recent surge in interest in the Medical Marijuana and Industrial Hemp space. The sector is quickly developing, as new Federal rules kicked in April 1 2014. It is important for investors to align themselves with companies that will actually deliver. There are several market figures floating around, but safe to say the market will grow exponentially over the next 5-10 years. Early exposure is likely warranted.
Supreme Extends Due Diligence and Cancels Private Placement
Marketwire - Tue Apr 15, 8:52AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (OTCBB: SPRWF)(TSX VENTURE: SL) reports that the parties to the agreement to acquire the South Okanagan producing medical marijuana facility, have mutually agreed upon an extension of the due diligence period to April 29th, 2014.
Supreme Enters Into Negotiations for an Additional Medical Marijuana Producing Facility
Marketwire - Mon Apr 14, 7:03AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (OTCBB: SPRWF) (TSX VENTURE: SL) reports that the Company has entered into negotiations with a producing medical marijuana facility to acquire that business. This is in addition to the South Okanagan producing facility currently under evaluation. The parties have agreed to an exclusive 45-day negotiating period. There is no guarantee that an agreement will be reached and will subject to regulatory approval.
Supreme Pharmaceuticals Inc.: Due Diligence Update
Marketwire - Wed Apr 09, 3:16PM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(PINKSHEETS: SPRWF) notes that in respect to its prior press release on Friday April 4, 2014, the Company will be utilizing the full 7 business days to complete and conclude the due diligence period. This means that the Company will report news on Tuesday, April 15, 2014 with a final decision on the South Okanagan producing medical marijuana facility.
Supreme Extends Due Diligence Period
Marketwire - Fri Apr 04, 2:35PM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(OTCBB: SPRWF) reports that the parties have extended the due diligence period in respect to the Company's peviously announced option agreement for an additional 7 business days until April 10, 2014. While due diligence results have been positive to date, the Company requires additional time to ensure the proper assessment of the South Okanagan producing facility before entering into the option.
Supreme Pharmaceuticals Inc.: Executive Management Visits Producing Facility as Part of Due Diligence
Marketwire - Tue Apr 01, 8:27AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (OTCBB: SPRWF)(TSX VENTURE: SL) advises that management is currently visiting the producing medical marijuana facility on which the Company may acquire an option to purchase, as part of its due diligence. The facility is located in the south Okanagan and the Company will get an onsite evaluation of the complex as it enters the final stages of the due diligence period. The 10 day due diligence period expires as of Friday April 4th, 2014. There is no assurance that the normal due diligence and other conditions will be met successfully and the option acquired. The Company will provide further updates as this matter progresses.
Supreme Pharmaceuticals Acquires Ontario Greenhouse Complex for Future Medical Marijuana Production
Marketwire - Fri May 23, 8:02AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Company"
(CSE: SL)(OTCBB: SPRWF) is pleased to announce that subsequent to its visit to the 342,000 square foot green house facility in Southern Ontario, Supreme has closed its purchase. The facility is located approximately 100 miles outside of Toronto. This facility is where production will commence after installation of the required security measures and subsequent receipt of final MMPR approval. The Company has started the process of upgrading the property. The facility is located in a specially created high energy use industrial park. It is located next to an unlimited supply of electricity at a very competitive rate, has year round road access and is conveniently located in respect to shipping logistics. It appears that all local use permits are in place such that production can commence immediately upon receipt of the final MMPR license. Supreme Pharmaceuticals Senior Management to Visit Southern Ontario Facility
Marketwire - Fri May 16, 11:49AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Company"
(CSE: SL)(OTCBB: SPRWF) is pleased to announce that senior management of the target company and of Supreme will visit the 342,000 square foot facility in Southern Ontario early next week, of which Supreme currently has the option to purchase. The facility is located approximately 100 miles outside of Toronto. This visit is part of the Company's due diligence on the facility where production is planned to commence upon implementation of the required security measures and receiving final MMPR approval. Major Medical Marijuana Acquisition Extends BC Company's Winning Streak
GlobeNewswire - Tue May 13, 9:30AM CDT
Needless to say, the M&A activity in the Medical Marijuana space is only going to pick up speed. Less than six weeks since the new Federal rules kicked in, companies are moving quickly to position themselves in this explosive market.
IIROC Trade Resumption - SL
CNW Group - Tue May 13, 9:14AM CDT
Trading resumes in:
Supreme Pharmaceuticals Inc. Announces Second Acquisition Target
Marketwire - Tue May 13, 9:02AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Company"
(CSE: SL)(OTCBB: SPRWF) is pleased to report that the Company has signed a letter of intent ("LOI" to acquire a green house facility and 100% of a Southern Ontario based company (the "Target Company" that has been approved for a pre-build Marijuana for Medical Purposes Regulations license ("MMPR Licence". Under the terms of the MMPR License, the Target Company can build out and operate a 342,000 square foot facility that can produce up to 24,000,000 grams (24,000 kilograms) of medicinal marijuana per year. Supreme has made an initial $250,000 payment under the terms of the LOI, and must, by May 22nd, 2014 advance to the Target Company an additional $750,000, at which time Supreme will own the Facility, as described below. The transaction terms contained in the LOI are binding on the parties, subject to final documentation. Supreme currently has the necessary funds on hand to close this portion of the transaction. IIROC Trading Halt - SL
CNW Group - Tue May 13, 8:00AM CDT
The following issues have been halted by IIROC:
Supreme Grants Incentive Options
Marketwire - Wed May 07, 5:07AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(CSE: SL)(OTCBB: SPRWF) has granted 12,000,000 incentive stock options to directors, officers and consultants at an exercise price of $0.05 for a term of five years from this day May 5th, 2014. In the Medical Marijuana Market, Pick a Winner
GlobeNewswire - Thu May 01, 9:40AM CDT
Most savvy investors are aware of the recent surge in interest in the Medical Marijuana and Industrial Hemp space. The sector is quickly developing, as new Federal rules kicked in April 1 2014. It is important for investors to align themselves with companies that will actually deliver. There are several market figures floating around, but safe to say the market will grow exponentially over the next 5-10 years. Early exposure is likely warranted.
Supreme Extends Due Diligence and Cancels Private Placement
Marketwire - Tue Apr 15, 8:52AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(OTCBB: SPRWF)(TSX VENTURE: SL) reports that the parties to the agreement to acquire the South Okanagan producing medical marijuana facility, have mutually agreed upon an extension of the due diligence period to April 29th, 2014. Supreme Enters Into Negotiations for an Additional Medical Marijuana Producing Facility
Marketwire - Mon Apr 14, 7:03AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(OTCBB: SPRWF) (TSX VENTURE: SL) reports that the Company has entered into negotiations with a producing medical marijuana facility to acquire that business. This is in addition to the South Okanagan producing facility currently under evaluation. The parties have agreed to an exclusive 45-day negotiating period. There is no guarantee that an agreement will be reached and will subject to regulatory approval. Supreme Pharmaceuticals Inc.: Due Diligence Update
Marketwire - Wed Apr 09, 3:16PM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(PINKSHEETS: SPRWF) notes that in respect to its prior press release on Friday April 4, 2014, the Company will be utilizing the full 7 business days to complete and conclude the due diligence period. This means that the Company will report news on Tuesday, April 15, 2014 with a final decision on the South Okanagan producing medical marijuana facility. Supreme Extends Due Diligence Period
Marketwire - Fri Apr 04, 2:35PM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(OTCBB: SPRWF) reports that the parties have extended the due diligence period in respect to the Company's peviously announced option agreement for an additional 7 business days until April 10, 2014. While due diligence results have been positive to date, the Company requires additional time to ensure the proper assessment of the South Okanagan producing facility before entering into the option. Supreme Pharmaceuticals Inc.: Executive Management Visits Producing Facility as Part of Due Diligence
Marketwire - Tue Apr 01, 8:27AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(OTCBB: SPRWF)(TSX VENTURE: SL) advises that management is currently visiting the producing medical marijuana facility on which the Company may acquire an option to purchase, as part of its due diligence. The facility is located in the south Okanagan and the Company will get an onsite evaluation of the complex as it enters the final stages of the due diligence period. The 10 day due diligence period expires as of Friday April 4th, 2014. There is no assurance that the normal due diligence and other conditions will be met successfully and the option acquired. The Company will provide further updates as this matter progresses. 
